Latest / Oncology Data Advisor
Analyzing Enzalutamide Patient-Reported Outcomes and QOL in the EMBARK Trial: Stephen Freedland, MD
This playlist features interviews recorded live by Oncology Data Advisor at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting in Chicago. Visit oncdata.com to learn more!
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.